| Dr Jaclyn Hess, MD | |
|
108 Dornach Way, Advance, NC 27006-7305 | |
| (336) 940-2407 | |
| Not Available |
| Full Name | Dr Jaclyn Hess |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 9 Years |
| Location | 108 Dornach Way, Advance, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154717544 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Davie Dermatology, P.a. | 0547241580 | 11 |
News Archive
The U.S. Food and Drug Administration (FDA) today announced approval of Follistim®-AQ TM cartridge (follitropin beta injection) in the United States. Follistim-AQ cartridge is the first follicle stimulating hormone (FSH) treatment available in a pre-filled, pre-mixed solution, eliminating the need for patients to mix one or more vials of medication.
Avanir Pharmaceuticals, Inc. today announced that it has entered into a settlement agreement with Actavis South Atlantic LLC and Actavis, Inc. (collectively, "Actavis") to resolve pending patent litigation in response to Actavis' abbreviated new drug application seeking approval to market generic versions of Avanir's NUEDEXTA (dextromethorphan hydrobromide/quinidine sulfate) capsules.
A multidisciplinary team of Michigan State University researchers has been awarded $4.2 million to develop accurate clinical research tools for studying osteopathic manipulative medicine, a hands-on approach to the diagnosis and treatment of musculoskeletal disorders.
Researchers have found that a drug currently used to treat Type 2 diabetes could treat addiction to drugs such as cocaine.
› Verified 1 days ago
| Entity Name | Davie Dermatology, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922060649 PECOS PAC ID: 0547241580 Enrollment ID: O20040526000880 |
News Archive
The U.S. Food and Drug Administration (FDA) today announced approval of Follistim®-AQ TM cartridge (follitropin beta injection) in the United States. Follistim-AQ cartridge is the first follicle stimulating hormone (FSH) treatment available in a pre-filled, pre-mixed solution, eliminating the need for patients to mix one or more vials of medication.
Avanir Pharmaceuticals, Inc. today announced that it has entered into a settlement agreement with Actavis South Atlantic LLC and Actavis, Inc. (collectively, "Actavis") to resolve pending patent litigation in response to Actavis' abbreviated new drug application seeking approval to market generic versions of Avanir's NUEDEXTA (dextromethorphan hydrobromide/quinidine sulfate) capsules.
A multidisciplinary team of Michigan State University researchers has been awarded $4.2 million to develop accurate clinical research tools for studying osteopathic manipulative medicine, a hands-on approach to the diagnosis and treatment of musculoskeletal disorders.
Researchers have found that a drug currently used to treat Type 2 diabetes could treat addiction to drugs such as cocaine.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jaclyn Hess, MD 2341 Kings Way, Augusta, GA 30904-4487 Ph: (336) 909-0222 | Dr Jaclyn Hess, MD 108 Dornach Way, Advance, NC 27006-7305 Ph: (336) 940-2407 |
News Archive
The U.S. Food and Drug Administration (FDA) today announced approval of Follistim®-AQ TM cartridge (follitropin beta injection) in the United States. Follistim-AQ cartridge is the first follicle stimulating hormone (FSH) treatment available in a pre-filled, pre-mixed solution, eliminating the need for patients to mix one or more vials of medication.
Avanir Pharmaceuticals, Inc. today announced that it has entered into a settlement agreement with Actavis South Atlantic LLC and Actavis, Inc. (collectively, "Actavis") to resolve pending patent litigation in response to Actavis' abbreviated new drug application seeking approval to market generic versions of Avanir's NUEDEXTA (dextromethorphan hydrobromide/quinidine sulfate) capsules.
A multidisciplinary team of Michigan State University researchers has been awarded $4.2 million to develop accurate clinical research tools for studying osteopathic manipulative medicine, a hands-on approach to the diagnosis and treatment of musculoskeletal disorders.
Researchers have found that a drug currently used to treat Type 2 diabetes could treat addiction to drugs such as cocaine.
› Verified 1 days ago
Aurleigh Stimmel, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 108 Dornach Way, Advance, NC 27006 Phone: 336-940-2407 Fax: 336-940-3038 | |
Frank Lacy, MD Dermatology Medicare: Medicare Enrolled Practice Location: 108 Dornach Way, Advance, NC 27006 Phone: 336-940-2407 Fax: 336-940-3038 |